Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors

Nav

General Info

Geography

Sweden (SWE)

Stockholm

Time period covered

01/1997 - 12/1998

Data type

Scientific literature

Keywords

Anthropometry, Blood disorders, Cholesterol, Blood pressure

Citation

Authors

Leander K, Malarstig A, Van't Hooft FM, Hyde C, Hellenius ML, Troutt JS, Konrad RJ, Ohrvik J, Hamsten A, de Faire U

Journal

Circulation

Volume

133

Issue

Pages

1230-9

Publication year

2016

Suggested citation

Leander K, Malarstig A, Van't Hooft FM, Hyde C, Hellenius ML, Troutt JS, Konrad RJ, Ohrvik J, Hamsten A, de Faire U. Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors. Circulation. 2016; 133(13): 1230-9.

GHDx Entry last modified on: Jul 20, 2021

Header sites

Search form

Main menu

Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors

Nav